Crossmark Global Holdings’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,590
| Closed | -$209K | – | 1373 |
|
|
2021
Q4 | $209K | Buy |
7,590
+600
| +9% | +$16.5K | ﹤0.01% | 1321 |
|
|
2021
Q3 | $226K | Sell |
6,990
-80
| -1% | -$2.59K | 0.01% | 1288 |
|
|
2021
Q2 | $216K | Buy |
7,070
+80
| +1% | +$2.44K | 0.01% | 1346 |
|
|
2021
Q1 | $213K | Buy |
+6,990
| New | +$213K | 0.01% | 1347 |
|
|
2019
Q2 | – | Sell |
-6,858
| Closed | -$228K | – | 1397 |
|
|
2019
Q1 | $228K | Sell |
6,858
-30
| -0.4% | -$997 | 0.01% | 1253 |
|
|
2018
Q4 | $200K | Sell |
6,888
-8,160
| -54% | -$237K | 0.01% | 1300 |
|
|
2018
Q3 | $692K | Sell |
15,048
-150
| -1% | -$6.9K | 0.02% | 759 |
|
|
2018
Q2 | $568K | Buy |
15,198
+560
| +4% | +$20.9K | 0.02% | 865 |
|
|
2018
Q1 | $433K | Sell |
14,638
-2,158
| -13% | -$63.8K | 0.01% | 1015 |
|
|
2017
Q4 | $577K | Sell |
16,796
-1,302
| -7% | -$44.7K | 0.01% | 887 |
|
|
2017
Q3 | $655K | Buy |
+18,098
| New | +$655K | 0.02% | 796 |
|
|
2016
Q3 | $655K | Buy |
+18,098
| New | +$655K | 0.02% | 796 |
|